Archives

by in
Entry Author Date Location
Houston Startup Vapogenix Aims to Build a Better Pain Drug 07/03/13 Texas
Domain-Backed Adynxx Enters the Wide Open World of Pain Drug R&D 08/07/12 San Francisco
Hydra Makes Progress in Pain With First Trial and New Partnership 02/15/12 Boston
Pacira Wins FDA Approval of Pain Drug, Cushioning Pain of 3Q Loss 10/31/11 New York
AdverseEvents.com Seeks to Keep Track of Drug Side Effects the Way the FDA Never Could 09/27/11 San Francisco
Nevro Raises $58M for Anti-Pain Device 07/20/11 San Francisco
Pfizer buys Icagen 07/20/11 New York
Institutes Of Medicine Pain Report May Aid Medical Device Makers 07/14/11 Boston
Durect Plunges on FDA Ruling 06/24/11 San Francisco
BioNanomatrix Moves HQ, Awarepoint CEO Talks Strategy, Ambit Raises $30 Million, & More San Diego Life Sciences News 06/16/11 San Diego
AcelRx Prices IPO 01/21/11 San Francisco
Omeros Nabs $25M from Paul Allen, State Life Sciences Fund to Pursue Elusive Drug Targets 10/25/10 Seattle
Zogenix Files for IPO, Orexigen Licenses Obesity Drug to Takeda, ImThera Raises Capital For Sleep Apnea, & More San Diego Life Science News 09/09/10 San Diego
San Diego’s Zogenix Files for $90M IPO to Expand Development of Needle-Free Injector and Pain Drugs 09/07/10 San Diego
San Diego’s Zogenix Moving Fast to Commercialize Drug-and-Device Combo 08/17/10 San Diego
Ascent Changes to Anchor 03/30/10 Boston
Cadence Pharmaceuticals’ Pain Reliever Handed Second Regulatory Setback 02/11/10 San Diego
Javelin Pharma Agrees to Merger with Myriad Pharma 12/21/09 Boston
Hydra, Cubist Seek New Pain Drugs 10/19/09 Boston
Cadence, Aiming to Reduce Narcotics Use in Hospitals, Gears Up to Market IV Pain Reliever 07/07/09 San Diego
Cadence Applies for FDA Approval 05/14/09 San Diego
Alkermes, Swinging For the Fence, Touts New Anti-Addiction Drug 04/07/09 Boston
And Then There Were 3 at TorreyPines Therapeutics 04/01/09 San Diego
Pfizer’s VC Leader, Barbara Dalton, on Corporate Venture and Northwest Deal Hunting 03/17/09 Seattle
Cadence Drug Fails to Prevent Hospital Infections; Company Scraps Program 03/12/09 San Diego
Biogen Idec Aims to Regenerate Damaged Nerves, Crack Multi-Billion Dollar Market 03/11/09 Boston
Cadence Raises $86.6M in Private Stock Offering 02/17/09 San Diego
Stopping Migraines Before They Hurt: NeurAxon Pursues New Pain Drug 02/02/09 Boston
Cadence Turns Attention to Marketplace, as IV Pain Reliever Reaches Goals in Clinical Trials 12/18/08 San Diego
Cadence Shares Boom as IV Pain Reliever Reaches Goal in Study 12/17/08 San Diego
Page 1 of 2 next page »